Copper complexes with superoxide dismutase (SOD) activity show a wide range o
f pharmacological activities. We have investigated the e
ffect o
f ([
N,
N′-bis(2-pyridylmethylene)-1,4-butanediamine]-(
N,
N′,
N″,
N))-Cu(II)-chloride (Cu-PuPy) and {[
N,
N′-bis(2-pyridylphenyl)methylene-1,4-butanediamine]-(
N,
N′,
N″,
N)}-Cu(II)-chloride (Cu-
PuPhePy) on the multiple catalytic
functions o
f rat brain NO synthase (NOS). Both drugs inhibited the
formation o
f l-citrulline as well as the enzymatic reduction o
f cytochrome c. The uncoupled oxidation o
f NADPH, catalyzed by neuronal NOS in the absence o
f l-arginine, was inhibited by Cu-PuPy but stimulated by Cu-PuPhePy, suggesting that the phenyl-substituted compound acts as a parasitic electron acceptor. Our data identi
fy copper complexes with SOD mimicking activity as a novel class o
f neuronal NOS inhibitors blocking the reductase (diaphorase) activity o
f the enzyme.